Abstract
IntroductionNo real-world studies have examined the tolerability of Nintedanib in patients with progressive fibrosing interstitial lung disease (PFILD), who are also taking Metformin for type 2 diabetes. Metformin may reduce...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
